IBRX PDUFA date:
128 business days to decision · 2027-01-06
ImmunityBio, Inc.'s — FDA decision expected January 6, 2027.
Key facts
PDUFA date2027-01-06
Business days away128
Drug / candidate
Indication—
CompanyImmunityBio, Inc.
Market-cap tierMid
Cohort decision-day move (history)±2% median
Cohort move is the historical median absolute decision-day move for this market-cap tier — history, not a prediction. See the full 2026 PDUFA calendar →
Not affiliated with or endorsed by the FDA. Informational and educational only — not investment advice. Verify against primary FDA / SEC / company filings. © 2026 pdufa.bio